This public procurement record has 2 releases in its history.

Award

12 Aug 2022 at 11:10

Tender

08 Mar 2022 at 11:50

Summary of the contracting process

The NHS England has awarded the contract for the "NHS Framework Agreement for South of England Branded - Tranche B and Annual" project. This pharmaceutical products procurement falls under the "goods" category and involves multiple suppliers providing branded medicines. The framework agreement covers Tranche B from 1 September 2022 to 31 August 2024 with extension options

This tender provides business growth opportunities for pharmaceutical companies looking to supply branded medicines to NHS England in the South of England region. The procurement method was an open procedure, and the suppliers awarded the lots include a mix of large and small-to-medium enterprises, indicating a diverse supplier base catering to the NHS's pharmaceutical needs.

How relevant is this notice?

Notice Title

NHS Framework Agreement for South of England Branded - Tranche B and Annual

Notice Description

CM/PHR/20/5611/01 - NHS Framework for SOUTH of England Branded Medicines - Tranche B<br/><br/>CM/PHR/20/5611/02 - NHS Framework for the SOUTH of England Branded Medicines - Annual Tranche

Lot Information

CM/PHR/20/5611/01 - NHS Framework for SOUTH of England Branded Medicines

NHS South of England Branded Medicines - Tranche B

Offer reference number: CM/PHR/20/5611

CM/PHR/20/5611/01 - NHS Framework for SOUTH of England Branded Medicines - Tranche B. Period of framework: 1 September 2022 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/20/5611/02 - NHS Framework for the SOUTH of England Branded Medicines - Annual Tranche. Period of framework: 1 September 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Additional information: Further to II.2.5 - Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: There will be an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/20/5611/02 - NHS Framework for the SOUTH of England Branded Medicines

NHS South of England Branded Medicines - Tranche B

Offer reference number: CM/PHR/20/5611

CM/PHR/20/5611/01 - NHS Framework for SOUTH of England Branded Medicines - Tranche B. Period of framework: 1 September 2022 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/20/5611/02 - NHS Framework for the SOUTH of England Branded Medicines - Annual Tranche. Period of framework: 1 September 2022 to 31 August 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Additional information: Further to II.2.5 - Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: There will be an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-031f24
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/022264-2022
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£875,718,494 £100M-£1B
Lots Value
£875,718,494 £100M-£1B
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
12 Aug 20224 years ago
Submission Deadline
12 Apr 2022Expired
Future Notice Date
Not specified
Award Date
15 Jul 20224 years ago
Contract Period
1 Sep 2022 - 31 Aug 2023 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS England
Additional Buyers

The NHS Commissioning Board (operating under the name of NHS England)

Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS2 7UE
Postcode Area
Leeds
Country
England

Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified

Local Authority
Leeds
Electoral Ward
Little London & Woodhouse
Westminster Constituency
Leeds Central and Headingley

Supplier Information

Number of Suppliers
29
Supplier Names

Accord-UK Ltd

Almirall

AstraZeneca

Aventis Pharma ltd t/a Sanofi

Bayer Plc

Biogen

CST Pharma Limited

Celltrion Healthcare United Kingdom Limited

Eli Lilly and Company Ltd

Gedeon Richter UK Ltd

GlaxoSmithKline UK Limited

Ipsen

Janssen-Cilag Ltd

Merck Serono Limited

Merck Sharpe and Dohme (UK) Limited

Mylan

Novo Nordisk

Organon Pharmaceuticals UK Ltd

Pfizer Ltd

Roche Products Ltd

Sandoz Ltd

Sobi (Swedish Orphan Biovitrum Ltd)

Takeda UK Ltd

Teva UK Limited

Thornton and Ross Ltd

Typharm Ltd

UCB Pharma Ltd (primary)

UL Global Pharma

Zentiva Pharma UK Ltd

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...